Log In
Print this Print this

INM176, WIN-026

Also known as: INM-176

  Manage Alerts
Collapse Summary General Information
Company Scigenic Co. Ltd.
DescriptionAntioxidant and anti-amyloid herb derivative
Molecular Target
Mechanism of ActionAntioxidant
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
PartnerWhanin Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today